Economic Benefit of Tuberculosis Control

Tuberculosis is the most important infectious cause of adult deaths after HIV/AIDS in low- and middle-income countries. This paper evaluates the economic benefits of extending the World Health Organization's DOTS Strategy (a multi-component ap...

Full description

Bibliographic Details
Main Authors: Laxminarayan, Ramanan, Klein, Eili, Dye, Christopher, Floyd, Katherine, Darley, Sarah, Adeyi, Olusoji
Format: Policy Research Working Paper
Language:English
Published: World Bank, Washington, DC 2012
Subjects:
HIV
SEX
TB
Online Access:http://documents.worldbank.org/curated/en/2007/08/8011024/economic-benefit-tuberculosis-control
http://hdl.handle.net/10986/7483
id okr-10986-7483
recordtype oai_dc
repository_type Digital Repository
institution_category Foreign Institution
institution Digital Repositories
building World Bank Open Knowledge Repository
collection World Bank
language English
topic ADULT MORTALITY
AGED
AGRICULTURAL DEVELOPMENT
AGRICULTURAL PRODUCTION
AIDS EPIDEMIC
BASIC EDUCATION
BLUEPRINT
BURDEN OF DISEASE
CAUSES OF DEATH
CHEMOTHERAPY
CHILD DEVELOPMENT
CHRONIC DISEASE
COMPLICATIONS
COUNSELING
CULTURAL CHANGE
DEATH RATE
DEATH RATES
DEMOGRAPHIC TRANSITION
DEVELOPING COUNTRIES
DIAGNOSTICS
DIET
DISABILITY
DISEASE
DISEASE BURDEN
DISEASE CONTROL
DISEASE OF POVERTY
DISEASE TRANSMISSION
DRUG RESISTANCE
DRUGS
ECONOMIC GROWTH
ECONOMIC PROSPERITY
ENDEMIC COUNTRIES
ENVIRONMENTAL PROTECTION
EPIDEMIC
EPIDEMICS
EPIDEMIOLOGISTS
EPIDEMIOLOGY
EQUILIBRIUM
EXISTING POPULATION
EXPENDITURES
FAMILIES
FAMILY MEMBERS
FERTILITY
FORECASTS
FUTURE GENERATIONS
GLOBAL HEALTH
HEALTH ECONOMICS
HEALTH INTERVENTIONS
HEALTH POLICY
HEALTH SECTOR
HEALTH SERVICES
HEALTH STATUS
HEALTH SYSTEMS
HIV
HIV TESTING
HOUSEHOLD INCOME
HUMAN CAPITAL
HUMAN DEVELOPMENT
HUMAN POPULATION
ILLNESS
IMMUNODEFICIENCY
INFECTION
INFECTIONS
INFECTIOUS DISEASES
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
INTERVENTION
INVESTMENT IN CHILDREN
IRON
JOURNAL OF MEDICINE
LABOR MARKET
LABOR SUPPLY
LIFE EXPECTANCY
LIVING CONDITIONS
LIVING STANDARDS
LONGER LIFE
LONGEVITY
LOW-INCOME COUNTRIES
LOW-INCOME COUNTRY
LUNG DISEASE
M. BOVIS
MALARIA
MALNUTRITION
MARKETING
MEDICAL RESEARCH
MEDICINE
MIGRATION
MILLENNIUM DEVELOPMENT GOALS
MINISTRY OF HEALTH
MORBIDITY
MORBIDITY AND MORTALITY
MORTALITY
MORTALITY DECLINE
MORTALITY DECLINES
MORTALITY RATE
MORTALITY REDUCTIONS
MORTALITY RISK
NUMBER OF DEATHS
NUTRITION
PACIFIC REGION
PATIENTS
POLICY RESEARCH
POLICY RESEARCH WORKING PAPER
POOR HEALTH
PREMATURE DEATH
PREVALENCE
PROBABILITY
PROGRESS
PUBLIC HEALTH
PUBLIC HEALTH PROGRAMS
QUALITY OF HEALTH
QUALITY OF LIFE
REMITTANCES
RESOURCE CONSTRAINTS
RESPECT
RISK FACTORS
RISK OF DEATH
RISK OF INFECTION
RISK-TAKING BEHAVIOR
RISKY BEHAVIOR
SCHOOL CHILDREN
SECONDARY SCHOOL
SEX
SOCIAL MOBILIZATION
SUB-SAHARAN AFRICA
SYNDROME
TB
TB CONTROL
TOBACCO
TRANSMISSION OF INFECTION
TRANSMISSION RATES
TREATMENT
TUBERCULOSIS
TUBERCULOSIS CONTROL
UNEMPLOYMENT
UNPROTECTED SEX
VACCINE
VACCINES
WESTERN EUROPE
WORKERS
WORLD HEALTH ORGANIZATION
YOUNG ADULTS
spellingShingle ADULT MORTALITY
AGED
AGRICULTURAL DEVELOPMENT
AGRICULTURAL PRODUCTION
AIDS EPIDEMIC
BASIC EDUCATION
BLUEPRINT
BURDEN OF DISEASE
CAUSES OF DEATH
CHEMOTHERAPY
CHILD DEVELOPMENT
CHRONIC DISEASE
COMPLICATIONS
COUNSELING
CULTURAL CHANGE
DEATH RATE
DEATH RATES
DEMOGRAPHIC TRANSITION
DEVELOPING COUNTRIES
DIAGNOSTICS
DIET
DISABILITY
DISEASE
DISEASE BURDEN
DISEASE CONTROL
DISEASE OF POVERTY
DISEASE TRANSMISSION
DRUG RESISTANCE
DRUGS
ECONOMIC GROWTH
ECONOMIC PROSPERITY
ENDEMIC COUNTRIES
ENVIRONMENTAL PROTECTION
EPIDEMIC
EPIDEMICS
EPIDEMIOLOGISTS
EPIDEMIOLOGY
EQUILIBRIUM
EXISTING POPULATION
EXPENDITURES
FAMILIES
FAMILY MEMBERS
FERTILITY
FORECASTS
FUTURE GENERATIONS
GLOBAL HEALTH
HEALTH ECONOMICS
HEALTH INTERVENTIONS
HEALTH POLICY
HEALTH SECTOR
HEALTH SERVICES
HEALTH STATUS
HEALTH SYSTEMS
HIV
HIV TESTING
HOUSEHOLD INCOME
HUMAN CAPITAL
HUMAN DEVELOPMENT
HUMAN POPULATION
ILLNESS
IMMUNODEFICIENCY
INFECTION
INFECTIONS
INFECTIOUS DISEASES
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
INTERVENTION
INVESTMENT IN CHILDREN
IRON
JOURNAL OF MEDICINE
LABOR MARKET
LABOR SUPPLY
LIFE EXPECTANCY
LIVING CONDITIONS
LIVING STANDARDS
LONGER LIFE
LONGEVITY
LOW-INCOME COUNTRIES
LOW-INCOME COUNTRY
LUNG DISEASE
M. BOVIS
MALARIA
MALNUTRITION
MARKETING
MEDICAL RESEARCH
MEDICINE
MIGRATION
MILLENNIUM DEVELOPMENT GOALS
MINISTRY OF HEALTH
MORBIDITY
MORBIDITY AND MORTALITY
MORTALITY
MORTALITY DECLINE
MORTALITY DECLINES
MORTALITY RATE
MORTALITY REDUCTIONS
MORTALITY RISK
NUMBER OF DEATHS
NUTRITION
PACIFIC REGION
PATIENTS
POLICY RESEARCH
POLICY RESEARCH WORKING PAPER
POOR HEALTH
PREMATURE DEATH
PREVALENCE
PROBABILITY
PROGRESS
PUBLIC HEALTH
PUBLIC HEALTH PROGRAMS
QUALITY OF HEALTH
QUALITY OF LIFE
REMITTANCES
RESOURCE CONSTRAINTS
RESPECT
RISK FACTORS
RISK OF DEATH
RISK OF INFECTION
RISK-TAKING BEHAVIOR
RISKY BEHAVIOR
SCHOOL CHILDREN
SECONDARY SCHOOL
SEX
SOCIAL MOBILIZATION
SUB-SAHARAN AFRICA
SYNDROME
TB
TB CONTROL
TOBACCO
TRANSMISSION OF INFECTION
TRANSMISSION RATES
TREATMENT
TUBERCULOSIS
TUBERCULOSIS CONTROL
UNEMPLOYMENT
UNPROTECTED SEX
VACCINE
VACCINES
WESTERN EUROPE
WORKERS
WORLD HEALTH ORGANIZATION
YOUNG ADULTS
Laxminarayan, Ramanan
Klein, Eili
Dye, Christopher
Floyd, Katherine
Darley, Sarah
Adeyi, Olusoji
Economic Benefit of Tuberculosis Control
relation Policy Research Working Paper; No. 4295
description Tuberculosis is the most important infectious cause of adult deaths after HIV/AIDS in low- and middle-income countries. This paper evaluates the economic benefits of extending the World Health Organization's DOTS Strategy (a multi-component approach that includes directly observed treatment, short course chemotherapy and several other components) as proposed in the Global Plan to Stop TB, 2006-2015. The authors use a model-based approach that combines epidemiological projections of averted mortality and economic benefits measured using value of statistical life for the Sub-Saharan Africa region and the 22 high-burden, tuberculosis-endemic countries in the world. The analysis finds that the economic benefits between 2006 and 2015 of sustaining DOTS at current levels relative to having no DOTS coverage are significantly greater than the costs in the 22 high-burden, tuberculosis-endemic countries and the Africa region. The marginal benefits of implementing the Global Plan to Stop TB relative to a no-DOTS scenario exceed the marginal costs by a factor of 15 in the 22 high-burden endemic countries, a factor of 9 (95% CI, 8-9) in the Africa region, and a factor of 9 (95% CI, 9-10) in the nine high-burden African countries. Uncertainty analysis shows that benefit-cost ratios of the Global Plan strategy relative to sustained DOTS were unambiguously greater than one in all nine high-burden countries in Africa and in Afghanistan, Pakistan, and Russia. Although HIV curtails the effect of the tuberculosis programs by lowering the life expectancy of those receiving treatment, the benefits of the Global Plan are greatest in African countries with high levels of HIV.
format Publications & Research :: Policy Research Working Paper
author Laxminarayan, Ramanan
Klein, Eili
Dye, Christopher
Floyd, Katherine
Darley, Sarah
Adeyi, Olusoji
author_facet Laxminarayan, Ramanan
Klein, Eili
Dye, Christopher
Floyd, Katherine
Darley, Sarah
Adeyi, Olusoji
author_sort Laxminarayan, Ramanan
title Economic Benefit of Tuberculosis Control
title_short Economic Benefit of Tuberculosis Control
title_full Economic Benefit of Tuberculosis Control
title_fullStr Economic Benefit of Tuberculosis Control
title_full_unstemmed Economic Benefit of Tuberculosis Control
title_sort economic benefit of tuberculosis control
publisher World Bank, Washington, DC
publishDate 2012
url http://documents.worldbank.org/curated/en/2007/08/8011024/economic-benefit-tuberculosis-control
http://hdl.handle.net/10986/7483
_version_ 1764402152142274560
spelling okr-10986-74832021-04-23T14:02:33Z Economic Benefit of Tuberculosis Control Laxminarayan, Ramanan Klein, Eili Dye, Christopher Floyd, Katherine Darley, Sarah Adeyi, Olusoji ADULT MORTALITY AGED AGRICULTURAL DEVELOPMENT AGRICULTURAL PRODUCTION AIDS EPIDEMIC BASIC EDUCATION BLUEPRINT BURDEN OF DISEASE CAUSES OF DEATH CHEMOTHERAPY CHILD DEVELOPMENT CHRONIC DISEASE COMPLICATIONS COUNSELING CULTURAL CHANGE DEATH RATE DEATH RATES DEMOGRAPHIC TRANSITION DEVELOPING COUNTRIES DIAGNOSTICS DIET DISABILITY DISEASE DISEASE BURDEN DISEASE CONTROL DISEASE OF POVERTY DISEASE TRANSMISSION DRUG RESISTANCE DRUGS ECONOMIC GROWTH ECONOMIC PROSPERITY ENDEMIC COUNTRIES ENVIRONMENTAL PROTECTION EPIDEMIC EPIDEMICS EPIDEMIOLOGISTS EPIDEMIOLOGY EQUILIBRIUM EXISTING POPULATION EXPENDITURES FAMILIES FAMILY MEMBERS FERTILITY FORECASTS FUTURE GENERATIONS GLOBAL HEALTH HEALTH ECONOMICS HEALTH INTERVENTIONS HEALTH POLICY HEALTH SECTOR HEALTH SERVICES HEALTH STATUS HEALTH SYSTEMS HIV HIV TESTING HOUSEHOLD INCOME HUMAN CAPITAL HUMAN DEVELOPMENT HUMAN POPULATION ILLNESS IMMUNODEFICIENCY INFECTION INFECTIONS INFECTIOUS DISEASES INTERNATIONAL JOURNAL OF EPIDEMIOLOGY INTERVENTION INVESTMENT IN CHILDREN IRON JOURNAL OF MEDICINE LABOR MARKET LABOR SUPPLY LIFE EXPECTANCY LIVING CONDITIONS LIVING STANDARDS LONGER LIFE LONGEVITY LOW-INCOME COUNTRIES LOW-INCOME COUNTRY LUNG DISEASE M. BOVIS MALARIA MALNUTRITION MARKETING MEDICAL RESEARCH MEDICINE MIGRATION MILLENNIUM DEVELOPMENT GOALS MINISTRY OF HEALTH MORBIDITY MORBIDITY AND MORTALITY MORTALITY MORTALITY DECLINE MORTALITY DECLINES MORTALITY RATE MORTALITY REDUCTIONS MORTALITY RISK NUMBER OF DEATHS NUTRITION PACIFIC REGION PATIENTS POLICY RESEARCH POLICY RESEARCH WORKING PAPER POOR HEALTH PREMATURE DEATH PREVALENCE PROBABILITY PROGRESS PUBLIC HEALTH PUBLIC HEALTH PROGRAMS QUALITY OF HEALTH QUALITY OF LIFE REMITTANCES RESOURCE CONSTRAINTS RESPECT RISK FACTORS RISK OF DEATH RISK OF INFECTION RISK-TAKING BEHAVIOR RISKY BEHAVIOR SCHOOL CHILDREN SECONDARY SCHOOL SEX SOCIAL MOBILIZATION SUB-SAHARAN AFRICA SYNDROME TB TB CONTROL TOBACCO TRANSMISSION OF INFECTION TRANSMISSION RATES TREATMENT TUBERCULOSIS TUBERCULOSIS CONTROL UNEMPLOYMENT UNPROTECTED SEX VACCINE VACCINES WESTERN EUROPE WORKERS WORLD HEALTH ORGANIZATION YOUNG ADULTS Tuberculosis is the most important infectious cause of adult deaths after HIV/AIDS in low- and middle-income countries. This paper evaluates the economic benefits of extending the World Health Organization's DOTS Strategy (a multi-component approach that includes directly observed treatment, short course chemotherapy and several other components) as proposed in the Global Plan to Stop TB, 2006-2015. The authors use a model-based approach that combines epidemiological projections of averted mortality and economic benefits measured using value of statistical life for the Sub-Saharan Africa region and the 22 high-burden, tuberculosis-endemic countries in the world. The analysis finds that the economic benefits between 2006 and 2015 of sustaining DOTS at current levels relative to having no DOTS coverage are significantly greater than the costs in the 22 high-burden, tuberculosis-endemic countries and the Africa region. The marginal benefits of implementing the Global Plan to Stop TB relative to a no-DOTS scenario exceed the marginal costs by a factor of 15 in the 22 high-burden endemic countries, a factor of 9 (95% CI, 8-9) in the Africa region, and a factor of 9 (95% CI, 9-10) in the nine high-burden African countries. Uncertainty analysis shows that benefit-cost ratios of the Global Plan strategy relative to sustained DOTS were unambiguously greater than one in all nine high-burden countries in Africa and in Afghanistan, Pakistan, and Russia. Although HIV curtails the effect of the tuberculosis programs by lowering the life expectancy of those receiving treatment, the benefits of the Global Plan are greatest in African countries with high levels of HIV. 2012-06-07T22:12:03Z 2012-06-07T22:12:03Z 2007-08 http://documents.worldbank.org/curated/en/2007/08/8011024/economic-benefit-tuberculosis-control http://hdl.handle.net/10986/7483 English Policy Research Working Paper; No. 4295 CC BY 3.0 IGO http://creativecommons.org/licenses/by/3.0/igo/ World Bank World Bank, Washington, DC Publications & Research :: Policy Research Working Paper Publications & Research